An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
Year: 2014
Type: article
Study design: Clinical Trial
Authors: Pierre Maison-Blanche, Shaker Dakhil, Ari Baron, Sylvie Rottey, Fred Millard, Gedske Daugaard, Jean-Pascal Machiels, William Conkright, Sunil Sharma, Patricia M. M. B. Soetekouw, Jeffrey Yachnin, Lisa Sengeløv, Peter Van Veldhuizen, Sanjiv S. Agarwala, Dorothée Sémiond, Mustapha Chadjaa, Liji Shen, James L. Wade
Institutions: Assistance Publique – Hôpitaux de Paris, Hôpital Bichat-Claude-Bernard, Cancer Center of Kansas, California Pacific Medical Center, Ghent University Hospital, University of California San Diego, Moores Cancer Center, Rigshospitalet, Cliniques Universitaires Saint-Luc, UCLouvain, KU Leuven, Huntsman Cancer Institute, Maastricht University Medical Centre, Uppsala University Hospital, Herlev Hospital, Kansas City VA Medical Center, Temple University, Sanofi (France), Sanofi (United States), Decatur Memorial Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Sanofi
OpenAlex ID: W2003996438